Research ArticleOriginal Article
Open Access

Epidemiological evaluation of an Acinetobacter baumannii outbreak observed at an intensive care unit

Tuğba K. Atik, Bülent Atik, Osman Kilinç, Bayhan Bektöre, Hülya Duran, Burak M. Selek, Nihan Ceken, Orhan Baylan and Mustafa Özyurt
Saudi Medical Journal August 2018, 39 (8) 767-772; DOI: https://doi.org/10.15537/smj.2018.8.22431

References

  1. ↵
    1. Cheng VCC,
    2. Wong SC,
    3. Chen JHK,
    4. So SYC,
    5. Wong SCY,
    6. Ho PL,
    7. et al.
    (2018) Control of multidrug-resistant Acinetobacter baumannii in Hong Kong:Role of environmental surveillance in communal areas after a hospital outbreak. Am J Infect Control 46:60–66.
    OpenUrlCrossRefPubMed
  2. ↵
    1. WHO Guidelines Approved by the Guidelines Review Committee
    (2017) Guidelines for the Prevention and Control of Carbapenem-Resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in Health Care Facilities (World Health Organization, Geneva).
  3. ↵
    1. Tanguy M,
    2. Kouatchet A,
    3. Tanguy B,
    4. Pichard É,
    5. Fanello S,
    6. Joly-Guillou ML
    (2017) Management of an Acinetobacter baumannii outbreak in an intensive care unit. Med Mal Infect 47:409–414.
    OpenUrl
  4. ↵
    1. World Health Organization
    (2009) WHO guidelines on hand hygiene in health care (World Health Organization, Geneva (CN)).
  5. ↵
    1. Liu WL,
    2. Liang HW,
    3. Lee MF,
    4. Lin HL,
    5. Lin YH,
    6. Chen CC,
    7. et al.
    (2014) The impact of inadequate terminal disinfection on an outbreak of imipenem-resistant Acinetobacter baumannii in an intensive care unit. PLoS One 9:e107975.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Park YS,
    2. Lee H,
    3. Lee KS,
    4. Hwang SS,
    5. Cho YK,
    6. Kim HY,
    7. et al.
    (2010) Extensively drug-resistant Acinetobacter baumannii:risk factors for acquisition and prevalent OXA-type carbapenemases--a multicentre study. Int J Antimicrob Agents 36:430–435.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Li P,
    2. Niu W,
    3. Li H,
    4. Lei H,
    5. Liu W,
    6. Zhao X,
    7. et al.
    (2015) Rapid detection of Acinetobacter baumannii and molecular epidemiology of carbapenem-resistant A baumannii in two comprehensive hospitals of Beijing, China. Front Microbiol 6:997.
    OpenUrl
  8. ↵
    1. Cai B,
    2. Echols R,
    3. Magee G,
    4. Arjona Ferreira JC,
    5. Morgan G,
    6. Ariyasu M,
    7. et al.
    (2017) Prevalence of Carbapenem-Resistant Gram-Negative Infections in the United States Predominated by Acinetobacter baumannii and Pseudomonas aeruginosa. Open Forum Infect Dis 4:ofx176.
    OpenUrlCrossRef
  9. ↵
    1. Pogue JM,
    2. Mann T,
    3. Barber KE,
    4. Kaye KS
    (2013) Carbapenem-resistant Acinetobacter baumannii:epidemiology, surveillance and management. Expert Rev Anti Infect Ther 11:383–393.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Ambler RP
    (1980) The structure of beta-lactamases. Philos Trans R Soc Lond B Biol Sci 289:321–331.
    OpenUrlCrossRefPubMed
  11. ↵
    1. WHO Guidelines Approved by the Guidelines Review Committee
    (2016) Guidelines on Core Components of Infection Prevention and Control Programmes at the National and Acute Health Care Facility Level (World Health Organization, Geneva).
    1. Cantey JB,
    2. Sreeramoju P,
    3. Jaleel M,
    4. Treviño S,
    5. Gander R,
    6. Hynan LS,
    7. et al.
    (2013) Prompt control of an outbreak caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit. J Pediatr 163:672–679.e1-3.
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    1. Nakamura K,
    2. Kaneko M,
    3. Abe Y,
    4. Yamamoto N,
    5. Mori H,
    6. Yoshida A,
    7. et al.
    (2016) Outbreak of extended-spectrum β-lactamase-producing Escherichia coli transmitted through breast milk sharing in a neonatal intensive care unit. J Hosp Infect 92:42–46.
    OpenUrlCrossRef
  14. ↵
    1. Rafei R,
    2. Kempf M,
    3. Eveillard M,
    4. Dabboussi F,
    5. Hamze M,
    6. Joly-Guillou ML
    (2014) Current molecular methods in epidemiological typing of Acinetobacter baumannii. Future Microbiol 9:1179–1194.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Meshkat Z,
    2. Salimizand H,
    3. Amini Y,
    4. Khakshoor M,
    5. Mansouri D,
    6. Farsiani H,
    7. et al.
    (2017) Molecular characterization and genetic relatedness of clinically Acinetobacter baumanii isolates conferring increased resistance to the first and second generations of tetracyclines in Iran. Ann Clin Microbiol Antimicrob 16:51.
    OpenUrl
  16. ↵
    1. Goering RV
    (2010) Pulsed field gel electrophoresis:a review of application and interpretation in the molecular epidemiology of infectious disease. Infect Genet Evol 10:866–875.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Garrity G,
    2. Brenner DJ,
    3. Krieg NR,
    4. Staley JR
    1. Brisou J,
    2. Prevot AR
    (2005) in Bergey's Manual of Systematic Bacteriology Volume 2:The proteobacteria, Part B:The Gammaproteobacteria, Family II:Moraxellaceae, Genus II:Acinetobacter, eds Garrity G, Brenner DJ, Krieg NR, Staley JR (Springer-Verlag, New York (USA)), 2th ed, pp 425–435.
  18. ↵
    1. Clinical and Laboratory Standards Institute
    (2014) Performance standards for antimicrobial susceptibility testing. Twenty-Fourth Informational Supplement (Clinical and Laboratory Standards Institute, Wayne (PA)), pp M100–S24.
  19. ↵
    1. Keskin H,
    2. Tekeli A,
    3. Dolapci İ,
    4. Öcal D
    (2014) Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples. Mikrobiyol Bul 48:365–376.
    OpenUrl
  20. ↵
    1. Woodford N,
    2. Ellington MJ,
    3. Coelho JM,
    4. Turton JF,
    5. Ward ME,
    6. Brown S,
    7. et al.
    (2006) Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27:351–353.
    OpenUrlCrossRefPubMedWeb of Science
  21. ↵
    1. Durmaz R,
    2. Otlu B,
    3. Koksal F,
    4. Hosoglu S,
    5. Ozturk R,
    6. Ersoy Y,
    7. et al.
    (2009) The optimization of a rapid pulsed-field gel electrophoresis protocol for the typing of Acinetobacter baumannii, Escherichia coli and Klebsiella spp. Jpn J Infect Dis 62:372–377.
    OpenUrlPubMed
  22. ↵
    1. Turabelidze D,
    2. Kotetishvili M,
    3. Kreger A,
    4. Morris JG Jr.,
    5. Sulakvelidze A
    (2000) Improved pulsed-field gel electrophoresis for typing vancomycin-resistant enterococci. J Clin Microbiol 38:4242–4245.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    1. Tenover FC,
    2. Arbeit RD,
    3. Goering RV,
    4. Mickelsen PA,
    5. Murray BE,
    6. Persing DH,
    7. et al.
    (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis:criteria for bacterial strain typing. J Clin Microbiol 33:2233–2239.
    OpenUrlFREE Full Text
  24. ↵
    1. Jamal S,
    2. Atrouni AA,
    3. Rafei R,
    4. Dabboussi F,
    5. Hamze M,
    6. Osman M
    (2018) Molecular mechanisms of antibiotic resistance in Acinetobacter baumannii with a special focus on its epidemiology in Lebanon. J Glob Antimicrob Resist 18.
  25. ↵
    1. Mezzatesta ML,
    2. Caio C,
    3. Gona F,
    4. Cormaci R,
    5. Salerno I,
    6. Zingali T,
    7. et al.
    (2014) Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy:considerations on in vitro assay of active drugs. Int J Antimicrob Agents 44:112–116.
    OpenUrlCrossRef
  26. ↵
    1. Nemec A,
    2. Krizova L,
    3. Maixnerova M,
    4. van der Reijden TJ,
    5. Deschaght P,
    6. Passet V,
    7. et al.
    (2011) Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU). Res Microbiol 162:393–404.
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    1. Teo J,
    2. Lim TP,
    3. Hsu LY,
    4. Tan TY,
    5. Sasikala S,
    6. Hon PY,
    7. et al.
    (2015) Extensively drug-resistant Acinetobacter baumannii in a Thai hospital:a molecular epidemiologic analysis and identification of bactericidal Polymyxin B-based combinations. Antimicrob Resist Infect Control 4:2.
    OpenUrl
  28. ↵
    1. Hammerum AM,
    2. Hansen F,
    3. Skov MN,
    4. Stegger M,
    5. Andersen PS,
    6. Holm A,
    7. et al.
    (2015) Investigation of a possible outbreak of carbapenem-resistant Acinetobacter baumannii in Odense, Denmark using PFGE, MLST and whole-genome-based SNPs. J Antimicrob Chemother 70:1965–1968.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Guo-Xin M,
    2. Dan-Yang S,
    3. Xi-Zhou G,
    4. Jun-Chang C,
    5. Rui W,
    6. Zhi-Gang C,
    7. et al.
    (2014) Laboratory to Clinical Investigation of Carbapenem Resistant Acinetobacter baumannii Outbreak in a General Hospital. Jundishapur J Microbiol 7:e13120.
    OpenUrl
  30. ↵
    1. Abdallah M,
    2. Olafisoye O,
    3. Cortes C,
    4. Urban C,
    5. Charles C,
    6. Landman D,
    7. et al.
    (2015) Reduction in the prevalence of carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in New York City. Am J Infect Control 43:650–652.
    OpenUrlCrossRefPubMed
  31. ↵
    1. Rezaei A,
    2. Fazeli H,
    3. Moghadampour M,
    4. Halaji M,
    5. Faghri J
    (2018) Determination of antibiotic resistance pattern and prevalence of OXA-type carbapenemases among Acinetobacter baumannii clinical isolates from inpatients in Isfahan, central Iran. Infez Med 26:61–66.
    OpenUrl
  32. ↵
    1. Noormohamed A,
    2. Fakhr MK
    (2014) Molecular Typing of Campylobacter jejuni and Campylobacter coli Isolated from Various Retail Meats by MLST and PFGE. Foods 3:82–93.
    OpenUrl
  33. ↵
    1. Ambrosi C,
    2. Aleandri M,
    3. Giordano A,
    4. Scribano D,
    5. Marazzato M,
    6. Zagaglia C,
    7. et al.
    (2016) Molecular characterisation of extensively drug-resistant Acinetobacter baumannii:First report of a new sequence type in Italy. J Glob Antimicrob Resist 7:154–156.
    OpenUrlCrossRef
  34. ↵
    1. Çetinkol Y,
    2. Telli M,
    3. AltunçekiçYıldırım A,
    4. Çalgın MK
    (2016) Evaluation of the efficacy of colistin/sulbactam combination on carbapenem-resistant Acinetobacter baumannii strains. Mikrobiyol Bul 50:460–465.
    OpenUrl
  35. ↵
    1. Karagöz A,
    2. Baran I,
    3. Aksu N,
    4. Acar S,
    5. Durmaz R
    (2014) [Characterization and determination of antibiotic resistance profiles of a single clone Acinetobacter baumannii strains isolated from blood cultures]. Mikrobiyol Bul 48:566–576, Turkish.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section